• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Ghana·Financial Services·EWPI
Share

Emerging World Pharma, Inc. Stocks

$ 0Last Updated 17.07.2026

Issuer Rating

Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 11930

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Emerging World Pharma, Inc. dedicates its resources to pharmaceutical enterprises that produce generic medications, specifically those operating within developing economies. The firm provides these companies with crucial manufacturing infrastructure, manages the hiring and skill-building of local personnel, and supplies necessary raw components. Their investment strategy is concentrated on pharmaceutical businesses that have secured agreements with religious organizations, various non-governmental groups, governmental bodies, and wholesale distributors. The company, established in 1997 with its base in Sunyani, Ghana, underwent a name change from Tubearoo, Inc. to Emerging World Pharma, Inc. in November 2009.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.08.2026 07:30

Shein is aiming for a valuation of up to $40 billion in its Hong Kong IPO — Reuters

05.08.2026 01:35

SpaceX Exceeded Revenue Expectations: Revenue Nearly Doubled Thanks to Starlink

05.08.2026 01:18

The S&P 500 hit a new record high for the first time since June, driven by earnings reports and hopes that the Strait of Hormuz would reopen

05.08.2026 00:27

SpaceX Shares Fell 8% After First-Quarter Earnings Report: Online

05.08.2026 00:00

Caterpillar Has Raised Its Revenue Growth Forecast Thanks to the AI Boom. Should You Buy the Stock?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026